| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | melanoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| FIMEPINOSTAT | Small molecule | thyroid cancer | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| MOCETINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | clear cell renal carcinoma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | colorectal carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | plasma cell leukemia | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | mycosis fungoides | Histone deacetylase 2 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| BELINOSTAT | Small molecule | Mantle cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ABEXINOSTAT | Small molecule | follicular lymphoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ABEXINOSTAT | Small molecule | sarcoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | T-cell non-Hodgkin lymphoma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| ROMIDEPSIN | Protein | gastric adenocarcinoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | acute lymphoblastic leukemia | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | melanoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | chronic myelomonocytic leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | peritoneum cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ROMIDEPSIN | Protein | follicular lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | oropharyngeal carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | prostate cancer | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | fallopian tube cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | adult acute lymphoblastic leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| FIMEPINOSTAT | Small molecule | high grade B-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | vaginal cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | leukemia | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | HIV infection | Histone deacetylase 2 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| PANOBINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase 2 inhibitor | 3.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | primary myelofibrosis | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MOCETINOSTAT | Small molecule | oral squamous cell carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | brain disease | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | anaplastic astrocytoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | glioblastoma multiforme | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | liver cancer | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 3.0 | - | ATC |
| VORINOSTAT | Small molecule | cancer | Histone deacetylase 2 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | colorectal adenocarcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | papillary thyroid carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | childhood acute myeloid leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | lymphoblastic lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | leiomyosarcoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | lymphoid neoplasm | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | T-cell non-Hodgkin lymphoma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| VORINOSTAT | Small molecule | neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | neuroblastoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | acute lymphoblastic leukemia | Histone deacetylase 2 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | nodal marginal zone B-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | gliosarcoma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | colorectal carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | follicular lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | adult T-cell leukemia/lymphoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | Burkitts lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | pancreatic ductal adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | HIV-1 infection | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | skin neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | pancreatic adenocarcinoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Niemann-Pick disease | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | ovarian cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | classic Hodgkin lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | neoplasm | Histone deacetylase 2 inhibitor | 4.0 | - | ATC |
| VORINOSTAT | Small molecule | colorectal carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | clear cell renal carcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | HIV infection | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Central Nervous System Neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | esophageal cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | spinal cord neoplasm | Histone deacetylase 2 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| MOCETINOSTAT | Small molecule | urothelial carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | Burkitts lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | anaplastic large cell lymphoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | anus cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ABEXINOSTAT | Small molecule | follicular lymphoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | acute lymphoblastic leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 3.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | small cell lung carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ABEXINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Waldenstrom macroglobulinemia | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | prostate cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | nasopharyngeal neoplasm | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| ROMIDEPSIN | Protein | cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | male breast carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | Uveal Melanoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | soft tissue sarcoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| QUISINOSTAT | Small molecule | ovarian cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| TACEDINALINE | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Uveal Melanoma | Histone deacetylase 2 inhibitor | 0.5 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | prostate adenocarcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | HIV infection | Histone deacetylase 2 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | liver cancer | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | rectum cancer | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | oropharyngeal carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | endometrioid carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | renal cell carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | HIV infection | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | clear cell renal carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| FIMEPINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | primary central chondrosarcoma | Histone deacetylase inhibitor | 2.0 | Suspended | ClinicalTrials |
| PANOBINOSTAT | Small molecule | thyroid carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | metastatic malignant neoplasm | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | chronic myelogenous leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | lung cancer | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| BELINOSTAT | Small molecule | carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 0.5 | Withdrawn | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | Mantle cell lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | mature T-cell and NK-cell non-Hodgkin lymphoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | urinary bladder cancer | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | adult acute lymphoblastic leukemia | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| MOCETINOSTAT | Small molecule | follicular lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | mixed glioma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| ENTINOSTAT | Small molecule | triple-negative breast cancer | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | glioma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | fallopian tube cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 0.5 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | mesothelioma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | urothelial carcinoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | nodal marginal zone B-cell lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | essential thrombocythemia | Histone deacetylase 2 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| ROMIDEPSIN | Protein | mycosis fungoides | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | vulva cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | acute leukemia of ambiguous lineage | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | melanoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 3.0 | Unknown status | ClinicalTrials |
| BELINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | HIV infection | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| BELINOSTAT | Small molecule | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| ENTINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| CUDC-101 | Small molecule | cancer | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | chronic myelogenous leukemia | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | peritoneum cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | ovarian cancer | Histone deacetylase 2 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | melanoma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | brain neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse intrinsic pontine glioma | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| BELINOSTAT | Small molecule | lymphoid neoplasm | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | pancreatic carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | oropharynx cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | nodular sclerosis Hodgkin lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | gliosarcoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| TACEDINALINE | Small molecule | lung cancer | Histone deacetylase inhibitor | 3.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | lung cancer | Histone deacetylase 2 inhibitor | 3.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | leukemia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | neoplasm of mature B-cells | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | neuroblastoma | Histone deacetylase 2 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse intrinsic pontine glioma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | prostate cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | peritoneum cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | gliosarcoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | ovarian neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | cancer | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | neoplasm | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | liposarcoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| MOCETINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | ovarian cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | sarcoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | kidney disease | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Juvenile Myelomonocytic Leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | ovarian clear cell cystadenocarcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | grade III glioma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast adenocarcinoma | Histone deacetylase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | HIV-1 infection | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | ovarian cancer | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ENTINOSTAT | Small molecule | pancreatic carcinoma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| CUDC-101 | Small molecule | head and neck malignant neoplasia | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | chronic graft versus host disease | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| PANOBINOSTAT | Small molecule | hepatocellular carcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | MALT lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | non-small cell lung carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Uveal Melanoma | Histone deacetylase 2 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 0.5 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | anaplastic oligodendroglioma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase 2 inhibitor | 4.0 | - | DailyMed |
| VORINOSTAT | Small molecule | malignant pleural mesothelioma | Histone deacetylase 2 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| PANOBINOSTAT | Small molecule | pancreatic carcinoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | infiltrating urothelial carcinoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | nasal cavity and paranasal sinus squamous cell carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 3.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | malignant epithelial tumor of ovary | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | anaplastic oligodendroglioma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | verrucous carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ROMIDEPSIN | Protein | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | Sezary's disease | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| CUDC-101 | Small molecule | liver cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | primary myelofibrosis | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | leukemia | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| CUDC-101 | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | renal pelvis/ureter urothelial carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | glioblastoma multiforme | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | leukemia | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | chronic lymphocytic leukemia | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | primary myelofibrosis | Histone deacetylase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| FIMEPINOSTAT | Small molecule | NUT midline carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT LACTATE | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | pituitary-dependent Cushing's disease | Histone deacetylase 2 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | neuroblastoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | HIV infection | Histone deacetylase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | renal cell carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | graft versus host disease | Histone deacetylase inhibitor | 4.0 | Recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | mycosis fungoides | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | ovarian mucinous cystadenocarcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | cancer | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | childhood acute lymphoblastic leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | malignant colon neoplasm | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | breast adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | mesothelioma | Histone deacetylase 2 inhibitor | 3.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | neoplasm | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse intrinsic pontine glioma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | esophageal adenocarcinoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | Thymic Carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | glioblastoma multiforme | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | Mantle cell lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | salivary gland squamous cell carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ABEXINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | pancreatic adenocarcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | acute promyelocytic leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | kidney cancer | Histone deacetylase inhibitor | 1.0 | Suspended | ClinicalTrials |
| ENTINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | soft tissue sarcoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | HIV infection | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | polycythemia vera | Histone deacetylase 2 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ENTINOSTAT | Small molecule | malignant colon neoplasm | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | glioblastoma multiforme | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ROMIDEPSIN | Protein | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 3.0 | Completed | ClinicalTrials |
| CUDC-101 | Small molecule | neoplasm | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ABEXINOSTAT | Small molecule | renal cell carcinoma | Histone deacetylase inhibitor | 3.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | diffuse intrinsic pontine glioma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | mycosis fungoides | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | mycosis fungoides | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | hematopoietic and lymphoid cell neoplasm | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | sickle cell anemia | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | graft versus host disease | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | malignant colon neoplasm | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | glioblastoma multiforme | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 4.0 | - | ATC |
| ROMIDEPSIN | Protein | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse intrinsic pontine glioma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| MOCETINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | rectum cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | neuroendocrine neoplasm | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | colorectal carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | urethra cancer | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| QUISINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | HIV infection | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | urinary bladder cancer | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| ROMIDEPSIN | Protein | neoplasm | Histone deacetylase inhibitor | 4.0 | - | ATC |
| VORINOSTAT | Small molecule | Mantle cell lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | cancer | Histone deacetylase 2 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| VORINOSTAT | Small molecule | HIV infection | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | medullary thyroid gland carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | unspecified peripheral T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | follicular lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | chronic lymphocytic leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | non-small cell lung carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | Malignant Ovarian Brenner Tumor | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | colorectal carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | hypopharyngeal carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | breast neoplasm | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | urinary bladder carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | myelofibrosis | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | acute lymphoblastic leukemia | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | ovarian serous cystadenocarcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | neuroendocrine neoplasm | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | colorectal carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | anus cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | metastatic malignant neoplasm | Histone deacetylase inhibitor | 1.0 | Suspended | ClinicalTrials |
| CUDC-101 | Small molecule | breast cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | T-cell non-Hodgkin lymphoma | Histone deacetylase 2 inhibitor | 4.0 | - | DailyMed |
| VORINOSTAT | Small molecule | brain cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| MOCETINOSTAT | Small molecule | leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | brain neoplasm | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | triple-negative breast cancer | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | acute lymphoblastic leukemia | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | myelofibrosis | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| PANOBINOSTAT | Small molecule | soft tissue sarcoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | polycythemia vera | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| BELINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | chronic lymphocytic leukemia | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | Endometrial Endometrioid Adenocarcinoma | Histone deacetylase inhibitor | 0.5 | Completed | ClinicalTrials |
| ABEXINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | papillary thyroid carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | prostate adenocarcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | rectum cancer | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | chronic lymphocytic leukemia | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| PANOBINOSTAT | Small molecule | nodular sclerosis Hodgkin lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | schizophrenia | Histone deacetylase 2 inhibitor | 0.5 | Withdrawn | ClinicalTrials |
| ROMIDEPSIN | Protein | acute promyelocytic leukemia | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | breast adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Unknown status | ClinicalTrials |
| ABEXINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | Uveal Melanoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | metastatic melanoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 3.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | gliosarcoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | gastric cancer | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | melanoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | penile cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast neoplasm | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT LACTATE | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MOCETINOSTAT | Small molecule | rhabdomyosarcoma | Histone deacetylase 2 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENTINOSTAT | Small molecule | male breast carcinoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | gliosarcoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | graft versus host disease | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | malignant glioma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | small cell lung carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | non-Hodgkins lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | laryngeal squamous cell carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | drug interaction | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Alzheimer disease | Histone deacetylase 2 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| BELINOSTAT | Small molecule | cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | prostate cancer | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | hepatocellular carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | pancreatic carcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| BELINOSTAT | Small molecule | Uveal Melanoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ABEXINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | gastric cancer | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | prostate adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | cervical cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ROMIDEPSIN | Protein | angioimmunoblastic T-cell lymphoma | Histone deacetylase inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| MOCETINOSTAT | Small molecule | lung cancer | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | glioblastoma multiforme | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | mycosis fungoides | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ROMIDEPSIN | Protein | mature T-cell and NK-cell non-Hodgkin lymphoma | Histone deacetylase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| PANOBINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | lung cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | multiple myeloma | Histone deacetylase 2 inhibitor | 3.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | male breast carcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | precursor T-cell lymphoblastic leukemia-lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | skin cancer | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | lymphoid neoplasm | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | anaplastic astrocytoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | medulloblastoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | inflammatory breast carcinoma | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | anaplastic large cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Crohn's disease | Histone deacetylase 2 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MOCETINOSTAT | Small molecule | Hodgkins lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | prostate adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | multiple myeloma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | male breast carcinoma | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | malignant colon neoplasm | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | melanoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | HIV-1 infection | Histone deacetylase inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | HIV-1 infection | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | unspecified peripheral T-cell lymphoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | breast adenocarcinoma | Histone deacetylase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | renal cell carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | multiple myeloma | Histone deacetylase inhibitor | 4.0 | - | DailyMed |
| BELINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | small intestine cancer | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| CUDC-101 | Small molecule | gastric cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | sickle cell anemia | Histone deacetylase 2 inhibitor | 2.0 | Terminated | ClinicalTrials |
| VORINOSTAT | Small molecule | male breast carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | Mantle cell lymphoma | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | malignant glioma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | renal cell carcinoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | mature T-cell and NK-cell non-Hodgkin lymphoma | Histone deacetylase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| VORINOSTAT | Small molecule | myelodysplastic syndrome | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | follicular thyroid carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | anaplastic astrocytoma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | Sezary's disease | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | renal pelvis/ureter urothelial carcinoma | Histone deacetylase inhibitor | 2.0 | Terminated | ClinicalTrials |
| ENTINOSTAT | Small molecule | central nervous system cancer | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| TACEDINALINE | Small molecule | pancreatic carcinoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Mantle cell lymphoma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | mature T-cell and NK-cell non-Hodgkin lymphoma | Histone deacetylase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | neoplasm | Histone deacetylase inhibitor | 4.0 | - | ATC |
| VORINOSTAT | Small molecule | melanoma | Histone deacetylase 2 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| PANOBINOSTAT | Small molecule | breast cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | small cell lung carcinoma | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| PANOBINOSTAT | Small molecule | prostate cancer | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | breast cancer | Histone deacetylase 2 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | lymphoma | Histone deacetylase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| PANOBINOSTAT | Small molecule | plasmacytoma | Histone deacetylase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BELINOSTAT | Small molecule | Thymoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | prostate cancer | Histone deacetylase 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| MOCETINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase 2 inhibitor | 1.0 | Completed | ClinicalTrials |
| ENTINOSTAT | Small molecule | acute myeloid leukemia | Histone deacetylase inhibitor | 2.0 | Suspended | ClinicalTrials |
| BELINOSTAT | Small molecule | Mantle cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | gastric cancer | Histone deacetylase 2 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BELINOSTAT | Small molecule | fallopian tube cancer | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | neuroblastoma | Histone deacetylase 2 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| VORINOSTAT | Small molecule | anaplastic astrocytoma | Histone deacetylase 2 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| ROMIDEPSIN | Protein | nodal marginal zone B-cell lymphoma | Histone deacetylase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| PANOBINOSTAT | Small molecule | diffuse large B-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| ROMIDEPSIN | Protein | anaplastic oligodendroglioma | Histone deacetylase inhibitor | 1.0 | Completed | ClinicalTrials |
| QUISINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| PANOBINOSTAT | Small molecule | Cutaneous T-cell lymphoma | Histone deacetylase inhibitor | 2.0 | Completed | ClinicalTrials |
| VORINOSTAT | Small molecule | mixed glioma | Histone deacetylase 2 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |